Literature DB >> 29485754

Management of long-lasting phantosmia: a systematic review.

Mohamad Z Saltagi1, Cyrus C Rabbani1,2, Jonathan Y Ting1,2, Thomas S Higgins3,4.   

Abstract

BACKGROUND: Interest in the pathophysiology and management of phantom smells has increased rapidly over the last decade. A PubMed search for the term "phantosmia" demonstrated a near-doubling of articles published on phantosmia within the past 7 years. We aimed to systematically review the literature on the management of phantosmia.
METHODS: The PubMed, EMBASE, and Cochrane databases were searched for articles published since January 1990, using terms combined with pertinent Boolean search operators. We included articles evaluating management of phantosmia written in the English language, with original data and a minimum of 6 months of follow-up, on at least 2 patients and with well-defined and measurable outcomes.
RESULTS: A total of 2151 unique titles were returned upon the initial search. Of these, 146 abstracts were examined, yielding 7 articles meeting the inclusion criteria. All articles were predominantly level 4 evidence. One prospective level 3 study was included. The studies included a total of 96 patients, with follow-up ranging from 6 months to 11 years. Endpoints were primarily based on subjective patient responses. Management options included observation and medical and surgical therapy. Olfactory mucosa excision was the only surgical intervention studied, with short-term symptomatic improvement in 10 of 11 patients. Forty-one patients were treated medically, which included antipsychotic, antimigraine, and antiseizure medications, transcranial stimulation, and topical cocaine application.
CONCLUSION: Despite increasing interest in the treatment of phantosmia and reports of successful therapies, there remains a paucity of data and lack of consensus regarding optimal management of this difficult condition.
© 2018 ARS-AAOA, LLC.

Entities:  

Keywords:  olfaction; olfactory disorders; olfactory excision; parosmia; phantom smell

Mesh:

Substances:

Year:  2018        PMID: 29485754     DOI: 10.1002/alr.22108

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  7 in total

1.  Propofol Total Intravenous Anesthesia as an Intervention for Severe Radiation-Induced Phantosmia in an Adolescent with Ependymoma.

Authors:  Kavitha C Raghavan; Angela S Camfield; John Lucas; Yousef Ismael; Michael G Rossi; Doralina L Anghelescu
Journal:  J Adolesc Young Adult Oncol       Date:  2019-10-23       Impact factor: 2.223

2.  Prescription Medication Use and Phantom Odor Perception Among US Adults.

Authors:  Kathleen E Bainbridge; Danita Byrd-Clark
Journal:  Chemosens Percept       Date:  2019-12-05       Impact factor: 1.833

3.  Phantosmia with COVID-19 Related Olfactory Dysfunction: Report of Nine Case.

Authors:  Akif İşlek; Mustafa Koray Balcı
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-03-12

4.  Qualitative Olfactory Disorders: Patient Experiences and Self-Management.

Authors:  Carl Philpott; Joanne Dixon; Duncan Boak
Journal:  Allergy Rhinol (Providence)       Date:  2021-09-22

5.  Phantosmia Among Pediatric, Adolescent, and Young Adult Patients Receiving Proton Beam Therapy.

Authors:  Shoshana J Rosenzweig; Stanislav Lazarev; Shaakir Hasan; Jana Fox; J Isabelle Choi; Charles B Simone; Suzanne L Wolden
Journal:  Adv Radiat Oncol       Date:  2021-12-25

6.  Short duration phantosmia changes in a post-COVID-19 patient in Bangladesh.

Authors:  Mohammad Ashraful Amin; Sabrina Nahin; Jannatul Ferdous; Md Faisal Kabir Rozars; Mohammad Delwer Hossain Hawlader
Journal:  Clin Case Rep       Date:  2022-03-22

7.  Phantom smells: a prevalent COVID-19 symptom that progressively sets in.

Authors:  Christophe Bousquet; Kamar Bouchoucha; Moustafa Bensafi; Camille Ferdenzi
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-09-29       Impact factor: 3.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.